Surfactant treatment in the ICU: Alternative interpretations of existing evidence

Paediatric Anaesthesia

Volumn 16, Issue 8, 2006, Pages 813-815

  Strohmaier, Wolfgang ^a   Marraro, Giuseppe ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL LUNG SURFACTANT;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTIFICIAL VENTILATION; CLINICAL TRIAL; DRUG EFFICACY; DRUG MEGADOSE; EDITORIAL; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; LUNG DISEASE; LUNG INJURY; LUNG LAVAGE; LUNG WEDGE PRESSURE; MORBIDITY; MORTALITY; NEONATAL RESPIRATORY DISTRESS SYNDROME; NONHUMAN; OUTCOME ASSESSMENT; PREMATURITY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ADULT; EVIDENCE-BASED MEDICINE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INTENSIVE CARE; INTENSIVE CARE UNITS; PULMONARY SURFACTANTS; RANDOMIZED CONTROLLED TRIALS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 33746158920     PISSN: 11555645     EISSN: 14609592     Source Type: Journal    
DOI: 10.1111/j.1460-9592.2006.02015.x     Document Type: Editorial

References (16)

1. Petty TL. Adult respiratory distress syndrome: definition and historical perspective. Clin Chest Med 1982; 3: 3-7.
2. Meyer KC, Zimmerman JJ. Inflammation and surfactant. Paediatr Respir Rev 2002; 3: 308-314.
3. Takeda S, Ishizaka A, Fujino Y et al. Time to change diagnostic criteria of ARDS: towards the disease entity-based subgrouping. Multicenter Clinical Trail Committee; Japan Society of Respiratory Care Medicine. Pulm Pharmacol Ther 2005; 18: 115-119.
4. Ferguson ND, Kacmarek RM, Chiche JD et al. Screening of ARDS patients using standardized ventilator settings: influence on enrollment in a clinical trial. Intensive Care Med 2004; 30: 1111-1116.
5. Bernard GR, Artigas A, Brigham KL et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818-824.
6. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342: 1301-1308.
7. Villar J, Kacmarek RM, Perez-Mendez L et al. A high positive end-expiratory pressure, low tidal volume ventilatory strategy improves outcome in persistent acute respiratory distress syndrome: a randomized, controlled trial. Crit Care Med 2006; 34: 1311-1318.
8. Ricard JD, Dreyfuss D, Saumon G. Ventilator-induced lung injury. Eur Respir J Suppl 2003; 42: 2s-9s.
9. Hubmayr RD. Perspective on lung injury and recruitment: a skeptical look at the opening and collapse story. Am J Respir Crit Care Med 2002; 165: 1647-1653.
10. Spragg RG, Lewis JF, Walmrath HD et al. Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome. N Engl J Med 2004; 351: 884-892.
11. Taeusch HW, de la Serna JB, Perez-Gil J et al. Inactivation of pulmonary surfactant due to serum-inhibited adsorption and reversal by hydrophilic polymers: experimental. Biophys J 2005; 89: 1769-1779.
12. Dargaville PA, Mills JF. Surfactant therapy for meconium aspiration syndrome: current status. Drugs 2005; 65: 2569-2591.
13. The less MAS trial: http://www.rch.org.au/neonatal_rch/research.cfm? doc_id=6953.
14. Marraro GA, Denaro C, Galassini E et al. BAL with surfactant in severe unilateral chest trauma. A randomized trial. Biol Neonate 2005; 87: 323-331.
15. Strohmaier W, Trupka A, Pfeiler C et al. Bilateral lavage with diluted surfactant improves lung function after unilateral lung contusion in pigs. Crit Care Med 2005; 33: 2286-2293.
16. Luchetti M, Ferrero F, Gallini C et al. Multicenter, randomized controlled study of porcine surfactant in severe respiratory syncytial virus-induced respiratory failure. Pediatr Crit Care Med 2002; 3: 261-268.